BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  Sutro Biopharma to Participate in Three Upcoming Investor Conferences

  Sutro Biopharma, Inc. today announced that Chief Executive Officer, Bill Newell , will participate in three upcoming virtual investor conferences.

  November 2, 2021

   · 

  3 min read
• Business

  CASI Pharmaceuticals To Report Third Quarter 2021 Financial Results And Host Conference Call November 12, 2021

  CASI Pharmaceuticals, Inc. today announced the Company will host a conference call reviewing the third quarter highlights at 8:00 a.m. EDT on Friday , November 12th , 2021.

  November 2, 2021

   · 

  1 min read
• Drug Development

  Bicycle Therapeutics Announces Publication of Article Highlighting Preclinical Data from BT7480 Program in the Journal for ImmunoTherapy of Cancer

  Bicycle Therapeutics plc today announced that an article highlighting preclinical data from BT7480, a tumor-targeted immune cell agonist (TICA) targeting Nectin-4 and agonizing CD137 (4-1BB), was published in the Journal for ImmunoTherapy of Cancer.

  November 2, 2021

   · 

  5 min read
• Business

  Incyte Reports 2021 Third Quarter Financial Results and Provides Updates on Key Clinical Programs

  Incyte Reports 2021 Third Quarter Financial Results and Provides Updates on Key Clinical Programs

  November 2, 2021

   · 

  30 min read
• Biotech Beach

  Kura Oncology to Participate in Credit Suisse Healthcare Conference

  Kura Oncology, Inc. today announced its participation in the Credit Suisse 30th Annual Healthcare Conference.

  November 2, 2021

   · 

  1 min read
• Business

  GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2021

  GlycoMimetics, Inc. (Nasdaq: GLYC) today reported its financial results for the quarter ended September 30, 2021 and highlighted recent events. Cash and cash equivalents at September 30, 2021 were $101.9 million.

  November 2, 2021

   · 

  8 min read
• Biotech Bay

  Avellino Donates $25,000 to National Keratoconus Foundation to Support World Keratoconus Day and Disease Education

  Avellino Lab USA, Inc. (Avellino), in honor of World Keratoconus Day, today announced a $25,000 donation to the National Keratoconus Foundation (NKCF)

  November 2, 2021

   · 

  5 min read
• RNA-based Therapeutics and Vaccines Market Report | How has COVID-19 affected the market?

  RNA-based biopharmaceuticals is a comparatively new class of treatment and it comprises vaccines and therapeutics.

  November 2, 2021

   · 

  5 min read
• Hemodynamic Monitoring Systems Market: Rising prevalence of cardiovascular diseases to drive the market

  Hemodynamic monitoring systems are used to examine the patient’s blood flow in detail and obtain various metrics about it, such as the amount of oxygen in the blood and the blood pressure inside various parts of the circulatory system.

  November 2, 2021

   · 

  7 min read
• Autoimmune Disease Diagnostics Market - Growing Instances of Autoimmune Diseases Drive the Market

  Autoimmune disease diagnostics market has gained traction due to growing efforts by several vendors undertaking research activities to discover novel biomarkers.

  November 2, 2021

   · 

  4 min read